SCHEMBL23993181

SCHEMBL23993181

CCC(CO)Nc1nc(N(Cc2ccccc2)C(C)C)c2ncn(C)c2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 12/20 0.64
▸ CCNA2 P20248 9/20 0.64
▸ CCNA1 P78396 9/20 0.64
▸ CDK1 P06493 10/20 0.52
▸ CDK5 Q00535 7/20 0.52
▸ DYRK1A Q13627 5/20 0.52
▸ CDK7 P50613 4/20 0.52
▸ CDK9 P50750 4/20 0.52
▸ CCNE1 P24864 4/20 0.52
▸ CCNK O75909 4/20 0.52
▸ CDK12 Q9NYV4 4/20 0.52
▸ CDK5R1 Q15078 4/20 0.52
▸ CACNA1B Q00975 3/20 0.52
▸ CCNB1 P14635 3/20 0.52
▸ CSNK1D P48730 2/20 0.52
▸ CLK2 P49760 2/20 0.52
▸ CSNK1G2 P78368 2/20 0.52
▸ CLK4 Q9HAZ1 2/20 0.52
▸ CSNK1G1 Q9HCP0 2/20 0.52
▸ CCNE2 O96020 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15387450 0.90 CDK1 (0.66) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL19111964 0.90 CDK1 (0.66) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL30356164 0.79 CDK1 (0.70) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL34470227 0.79 CDK1 (0.70) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL29684386 0.79 CDK1 (0.67) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL23752348 0.79 CDK1 (0.67) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL19112159 0.79 CDK1 (0.70) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL19111944 0.79 CDK1 (0.67) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL19112165 0.79 CDK1 (0.70) CDK2CCNA2CCNA1CDK1CDK5
SCHEMBL17628609 0.79 CDK2 (0.59) CDK2CCNA2CCNA1CDK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901154-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2021-10-27 — — EP disclosed
Send feedback